share_log

T2 Biosystems | 8-K: T2 Biosystems Announces the Resignation of Thierry Bernard as Director II and All Committees of the Company's Board of Directors

SEC announcement ·  Jan 5 13:00
Summary by Futu AI
On January 2, 2024, T2 Biosystems, Inc., a company registered in Delaware and listed on The Nasdaq Capital Market under the trading symbol TTOO, announced the immediate resignation of Thierry Bernard from his position as a Class II director. Bernard's resignation, detailed in a written letter, was not due to any disputes or disagreements with the company or its management but was attributed to other personal commitments. Bernard was a member of the company's Audit Committee prior to his departure. The Audit Committee will continue with David Elsbree as Chairman, alongside members Ninfa Saunders and Seymour Liebman.
On January 2, 2024, T2 Biosystems, Inc., a company registered in Delaware and listed on The Nasdaq Capital Market under the trading symbol TTOO, announced the immediate resignation of Thierry Bernard from his position as a Class II director. Bernard's resignation, detailed in a written letter, was not due to any disputes or disagreements with the company or its management but was attributed to other personal commitments. Bernard was a member of the company's Audit Committee prior to his departure. The Audit Committee will continue with David Elsbree as Chairman, alongside members Ninfa Saunders and Seymour Liebman.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.